# Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

> **NCT06800651** · PHASE2 · RECRUITING · sponsor: **Jemincare** · enrollment: 135 (estimated)

## Conditions studied

- ADPKD (Autosomal Dominant Polycystic Kidney Disease)

## Interventions

- **DRUG:** JMKX003142 will be administered orally
- **DRUG:** Plcacebo

## Key facts

- **NCT ID:** NCT06800651
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-13
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-05-30
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06800651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06800651, "Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06800651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*